AWA
MTNB icon

Arkadios Wealth Advisors’s Matinas BioPharma MTNB Stock Holding History

Arkadios Wealth Advisors’s Portfolio MTNB Stock Details MTNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-32,480
Closed -$440K – 896
2024
Q1 		$440K Hold
32,480
– – 0.03% 408
2023
Q4 		$351K Buy
32,480
+4,500
+16% +$50.8K 0.03% 466
2023
Q3 		$182K Hold
27,980
– – 0.02% 624
2023
Q2 		$504K Hold
27,980
– – 0.06% 305
2023
Q1 		$658K Hold
27,980
– – 0.08% 249
2022
Q4 		$700K Hold
27,980
– – 0.09% 228
2022
Q3 		$890K Hold
27,980
– – 0.14% 171
2022
Q2 		$1.1M Hold
27,980
– – 0.16% 161
2022
Q1 		$1.13M Hold
27,980
– – 0.15% 169
2021
Q4 		$1.41M Hold
27,980
– – 0.19% 130
2021
Q3 		$1.82M Buy
27,980
+20,980
+300% +$905K 0.26% 96
2021
Q2 		$271K Buy
+7,000
New +$301K 0.03% 467

Other funds holding MTNB

HCM
Highbridge Capital Management New York $1.58B AUM 31.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AWMG
Alliance Wealth Management Group Flemington, New Jersey $457M AUM 12.13% 1-Year Est. Return
TCM
Towercrest Capital Management Newtown, Pennsylvania $642M AUM 11.71% 1-Year Est. Return
NRS
Neville Rodie & Shaw New York $1.55B AUM 46.95% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return